NCT04281758View on ClinicalTrials.gov

Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

October 1, 2020

Study Completion Date

October 13, 2020

Conditions
Plasma Caffeine Concentration
Interventions
OTHER

Beverage

16 oz (473.2 ml)

Trial Locations (1)

55114

Prism Clinical Research, Saint Paul

All Listed Sponsors
lead

PepsiCo Global R&D

INDUSTRY

NCT04281758 - Comparison of Plasma Caffeine Concentration After Oral Consumption of Caffeinated Beverages With Varied Bioactive Compounds in Healthy Volunteers | Biotech Hunter | Biotech Hunter